Medicare Enrolled

Dr. Rikk Lynn, M.D.

Dermatology · Santa Barbara, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
601 E ARRELLAGA ST, Santa Barbara, CA 93103
8059441130
In practice since 2007 (18 years)
NPI: 1437355260 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lynn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lynn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lynn

Dr. Rikk Lynn is a dermatology specialist in Santa Barbara, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lynn performed 3,913 Medicare services across 1,914 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lynn received a total of $20,683 from 36 pharmaceutical and/or device companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lynn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 32% volume in CA $20,683 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,913
Medicare services
Top 32% in CA for dermatology
1,914
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~217 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,819 $6 $74
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
565 $95 $423
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
552 $44 $241
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
270 $72 $207
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
211 $91 $330
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
142 $71 $240
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
116 $78 $431
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
65 $127 $879
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
43 $29 $120
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
29 $11 $129
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
22 $40 $143
Telephone or electronic consultation, at least 5 minutes
A remote assessment and management service provided by a consulting physician via telephone, internet, or electronic health record. The service requires at least 5 minutes of time and includes a written report.
18 $27 $148
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $141 $547
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $43 $79
Destruction of skin growth, 15 or more growths 14 $107 $387
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
14 $154 $552
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,683
Total received (2018-2024)
Avg $2,955/year across 7 years
Top 10% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
387
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,381 (64.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,916 (33.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$386 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,566
2023
$1,331
2022
$1,223
2021
$718
2020
$531
2019
$960
2018
$14,354

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$559
UCB, Inc.
$103
Incyte Corporation
$97
Janssen Biotech, Inc.
$93
PFIZER INC.
$92
SUN PHARMACEUTICAL INDUSTRIES INC.
$91
Lilly USA, LLC
$77
Verrica Pharmaceuticals Inc.
$74
Novartis Pharmaceuticals Corporation
$73
LEO Pharma Inc.
$57
GENZYME CORPORATION
$47
Regeneron Healthcare Solutions, Inc.
$43
Amgen Inc.
$41
E.R. Squibb & Sons, L.L.C.
$31
Organon Llc
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Arcutis Biotherapeutics, Inc.
$20
Dermavant Sciences, Inc.
$14
Top 3 companies account for 48.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$5,976
Janssen Biotech, Inc.
$4,871
UCB, Inc.
$3,704
ABBVIE INC.
$1,290
Novartis Pharmaceuticals Corporation
$990
Lilly USA, LLC
$551
GENZYME CORPORATION
$383
AbbVie Inc.
$331
Regeneron Healthcare Solutions, Inc.
$321
Sun Pharmaceutical Industries Inc.
$286
Amgen Inc.
$219
Merz North America, Inc.
$209
SUN PHARMACEUTICAL INDUSTRIES INC.
$175
PFIZER INC.
$157
Celgene Corporation
$152
Incyte Corporation
$122
LEO Pharma Inc.
$115
Janssen Scientific Affairs, LLC
$106
E.R. Squibb & Sons, L.L.C.
$86
Ortho Dermatologics, a division of Bausch Health US, LLC
$81
Verrica Pharmaceuticals Inc.
$74
MERZ NORTH AMERICA, INC.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Genentech USA, Inc.
$55
EPI Health, LLC
$47
Dermavant Sciences, Inc.
$39
Blueprint Medicines Corporation
$30
Almirall LLC
$27
Organon Llc
$27
Mayne Pharma Inc.
$26
ARRAY BIOPHARMA INC
$25
SANOFI-AVENTIS U.S. LLC
$23
Encore Dermatology Inc.
$23
Arcutis Biotherapeutics, Inc.
$20
DUSA Pharmaceuticals, Inc.
$18
Biofrontera Inc.
$14
Top 3 companies account for 70.4% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · Absorica LD · Ameluz · BLU-U · BRAFTOVI · Bimzelx · CLODERM · COSENTYX · Cimzia · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · Erivedge · HADLIMA · HUMIRA · Humira · ILUMYA · Ilumya · Impoyz · Klisyri · ODOMZO · OPZELURA · Odomzo · Otezla · REMICADE · RINVOQ · Rituxan · SILIQ · SKYRIZI · SPEVIGO · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Winlevi · XEOMIN · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for dermatology in CA.

Looking for a dermatology specialist in Santa Barbara?
Compare dermatologists in the Santa Barbara area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
30
Per 100K population
6.8
County median income
$95,977
Nearest hospital
SANTA BARBARA COUNTY PSYCHIATRIC HEALTH FACILITY
5.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lynn is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 10% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lynn experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Lynn performed 1,819 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lynn receive payments from pharmaceutical companies?
Yes. Dr. Lynn received a total of $20,683 from 36 companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lynn's costs compare to other dermatologists in Santa Barbara?
Dr. Lynn's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lynn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →